Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Swimming Bio-Bots Designed to Traverse Biologic Aquatic Environments

By BiotechDaily International staff writers
Posted on 27 Jan 2014
Image: Engineers developed the first tiny, synthetic machines that can swim by themselves, powered by beating heart cells (Photo courtesy of Alex Jerez Roman, Beckman Institute for Advanced Science and Technology).
Image: Engineers developed the first tiny, synthetic machines that can swim by themselves, powered by beating heart cells (Photo courtesy of Alex Jerez Roman, Beckman Institute for Advanced Science and Technology).
Scientists have devised synthetic, tiny self-propelled swimming bio-bots that are able to move through the aquatic fluids of the body.

A team of engineers has developed a type of tiny bio-hybrid machines that swim similar to sperm, the first synthetic structures that can traverse the viscous fluids of biologic environments by themselves. A report on the study led by Taher Saif, a University of Illinois (I of U; Urbana-Champaign, USA) professor of mechanical science and engineering, was published on January 18, 2014, in the journal Nature Communications. “Microorganisms have a whole world that we only glimpse through the microscope,” Prof. Saif said. “This is the first time that an engineered system has reached this underworld.”

The engineers started by creating the body of the bio-bot from a flexible polymer. Then they cultured heart cells near the junction of the head and the tail. The cells self-align and synchronize to beat together, sending a wave down the tail that pushes the bio-bot forward.

This self-organization is an amazing new phenomenon, according to Prof. Saif; however, how the cells talk with each other on the flexible polymer tail is yet to be effectively determined. However, the cells need to beat together, in the right direction, for the tail to move. “It’s the minimal amount of engineering—just a head and a wire,” Prof. Saif said. “Then the cells come in, interact with the structure, and make it functional.”

The researchers also constructed two-tailed bots, which they found could swim even faster. Multiple tails also creates new avenues of navigation. The researchers foresee future bots that could sense or light or chemicals and move toward a target for medical or environmental applications. “The long-term vision is simple,” said Prof. Saif, who is also from the Beckman Institute for Advanced Science and Technology at the U of I. “Could we make elementary structures and seed them with stem cells that would differentiate into smart structures to deliver drugs, perform minimally invasive surgery or target cancer?”

The swimming bio-bot project is part of a larger US National Science Foundation-supported Science and Technology Center on Emergent Behaviors in Integrated Cellular Systems, which also produced the walking bio-bots developed at Illinois in 2012.

“The most intriguing aspect of this work is that it demonstrates the capability to use computational modeling in conjunction with biological design to optimize performance, or design entirely different types of swimming bio-bots,” said center director Dr. Roger Kamm, a professor of biological and mechanical engineering at the Massachusetts Institute of Technology (MIT; Cambridge MA, USA). “This opens the field up to a tremendous diversity of possibilities--truly an exciting advance.”

Related Links:

University of Illinois



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Diagram illustrates the innovative process that could lead to more effective drugs against influenza infection (Photo courtesy of the Hebrew University of Jerusalem).

Researchers Show How the Influenza Virus Blocks Natural Killer Cell Recognition

A team of molecular virologists has described how the influenza virus evolved a defense mechanism to protect it from attack by the immune system's natural killer (NK) cells. The recognition of pathogen-infected... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.